Patients' and doctors' assessment of adalimumab self injection: a multicenter questionnaire survey- Pearl survey 2
Not Applicable
Recruiting
- Conditions
- Crohn's disease, Ulcerative colitis and intestinal Behchet disease
- Registration Number
- JPRN-UMIN000035842
- Lead Sponsor
- Osaka City University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who do not give consent to participate in the survey.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Satisfaction rate of adalimumab self injection for pen type
- Secondary Outcome Measures
Name Time Method Pain of adalimumab self injection. Adherence of adalimumab self injection. Anxiety of adalimumab self injection. Difference in recognition of adalimumab self-injection among patients - doctors etc